• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-579-3p 通过调节 Sirt1 抑制间充质干细胞的成骨分化,促进骨质疏松的进展。

MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.

机构信息

Department of Orthopedics, The Affiliated Hospital (Traditional Chinese Medicine) of Southwest Medical University, Luzhou, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6791-6799. doi: 10.26355/eurrev_201908_18717.

DOI:10.26355/eurrev_201908_18717
PMID:31486477
Abstract

OBJECTIVE

To explore whether microRNA-579-3P was involved in the development of osteoporosis, and to investigate the possible molecular mechanisms.

PATIENTS AND METHODS

The messenger RNA (mRNA) expression levels of microRNA-579-3P, alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2) and bone sialoprotein (BSP) in serum samples of osteoporosis patients and normal controls were detected by quantitative Real-time polymerase chain reaction (qRT-PCR), respectively. Meanwhile, the expressions of the above genes during osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs) were examined as well. To investigate the effect of microRNA-579-3P on osteogenesis, microRNA-579-3P was overexpressed and knocked down in hMSCs. Subsequently, the mRNA and protein expression levels of osteogenesis-related genes, such as ALP, RUNX2 and BSP, were detected by qRT-PCR and Western blot, respectively. In addition, ALP activity and mineralization forming ability were evaluated by ALP staining and alizarin red staining. Bioinformatics predicted that Sirt1 was the target gene of microRNA-579-3P. Subsequent luciferase reporter gene assay was performed to verify the binding relationship of microRNA-579-3P to Sirt1. Meanwhile, qRT-PCR and Western blot were used to detect the changes in the mRNA and protein expression levels of Sirt1, respectively. After overexpression of microRNA-579-3P and Sirt1, qRT-PCR, Western blot, ALP staining and alizarin red staining assays were performed to detect the osteogenic differentiation of hMSCs.

RESULTS

The expression of microRNA-579-3P in serum of patients with osteoporosis was significantly higher than that of normal controls. Meanwhile, the expression of microRNA-579-3P decreased gradually during osteogenic differentiation of hMSCs. Overexpression of microRNA-579-3P significantly reduced the expressions of osteogenic related genes, including ALP, RUNX2 and BSP. Besides, ALP activity and mineralized nodule formation ability decreased obviously as well. Luciferase reporter gene assay showed that microRNA-579-3P could bind to Sirt1. After overexpression of microRNA-579-3P, the mRNA and protein expression levels of Sirt1 were significantly reduced, which were reversed after silence of microRNA-579-3P. Simultaneous overexpression of microRNA-579-3P and Sirt1 could reverse the inhibition of osteogenic differentiation of hMSCs caused by overexpression of microRNA-579-3P alone.

CONCLUSIONS

MicroRNA-579-3P could inhibit osteogenic differentiation of hMSCs by regulating Sirt1, thereby promoting the development of osteoporosis.

摘要

目的

探讨 microRNA-579-3P 是否参与骨质疏松症的发生发展,并探讨其可能的分子机制。

方法

采用实时定量聚合酶链反应(qRT-PCR)分别检测骨质疏松症患者和正常对照者血清中 microRNA-579-3P、碱性磷酸酶(ALP)、 runt 相关转录因子 2(RUNX2)和骨涎蛋白(BSP)的信使 RNA(mRNA)表达水平。同时,检测人骨髓间充质干细胞(hMSCs)成骨分化过程中上述基因的表达情况。为了研究 microRNA-579-3P 对成骨的影响,在 hMSCs 中转染 microRNA-579-3P 过表达和敲低载体。随后,采用 qRT-PCR 和 Western blot 分别检测成骨相关基因(如 ALP、RUNX2 和 BSP)的 mRNA 和蛋白表达水平。此外,通过碱性磷酸酶染色和茜素红染色评估 ALP 活性和矿化形成能力。生物信息学预测 Sirt1 是 microRNA-579-3P 的靶基因。随后进行荧光素酶报告基因实验验证 microRNA-579-3P 与 Sirt1 的结合关系。同时,采用 qRT-PCR 和 Western blot 分别检测 Sirt1 的 mRNA 和蛋白表达水平的变化。过表达 microRNA-579-3P 和 Sirt1 后,进行 qRT-PCR、Western blot、碱性磷酸酶染色和茜素红染色实验,检测 hMSCs 的成骨分化情况。

结果

骨质疏松症患者血清中 microRNA-579-3P 的表达明显高于正常对照组。同时,在 hMSCs 成骨分化过程中,microRNA-579-3P 的表达逐渐降低。microRNA-579-3P 过表达显著降低了成骨相关基因(包括 ALP、RUNX2 和 BSP)的表达。此外,ALP 活性和矿化结节形成能力明显降低。荧光素酶报告基因实验表明,microRNA-579-3P 可与 Sirt1 结合。过表达 microRNA-579-3P 后,Sirt1 的 mRNA 和蛋白表达水平明显降低,沉默 microRNA-579-3P 后则逆转。同时过表达 microRNA-579-3P 和 Sirt1 可逆转 microRNA-579-3P 过表达单独引起的 hMSCs 成骨分化抑制。

结论

microRNA-579-3P 可能通过调节 Sirt1 抑制 hMSCs 的成骨分化,从而促进骨质疏松症的发生发展。

相似文献

1
MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.微小 RNA-579-3p 通过调节 Sirt1 抑制间充质干细胞的成骨分化,促进骨质疏松的进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6791-6799. doi: 10.26355/eurrev_201908_18717.
2
MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.微小 RNA-1286 通过调控 FZD4 的表达抑制间充质干细胞的成骨分化从而促进骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):1-10. doi: 10.26355/eurrev_202001_19889.
3
MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.miRNA-19a-3p 通过靶向 HDAC4 促进 hMSCs 的成骨分化来缓解骨质疏松症的进展。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):666-672. doi: 10.1016/j.bbrc.2019.06.083. Epub 2019 Jun 24.
4
MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.微小 RNA-200a-3p 通过靶向谷氨酰胺酶抑制骨髓间充质干细胞的成骨分化来加速骨质疏松的进展。
Biomed Pharmacother. 2019 Aug;116:108960. doi: 10.1016/j.biopha.2019.108960. Epub 2019 May 18.
5
MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3.miRNA-27a-3p 通过靶向 ATF3 促进人骨髓间充质干细胞的成骨分化。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):73-80. doi: 10.26355/eurrev_201908_18632.
6
Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis.特立帕肽通过 miR-375/RUNX2 轴促进 hMSCs 的成骨分化来缓解骨质疏松症。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):11043-11050. doi: 10.26355/eurrev_201912_19812.
7
Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.miR-339的下调通过靶向DLX5促进骨髓间充质干细胞分化并减轻骨质疏松症。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):29-36. doi: 10.26355/eurrev_201901_16744.
8
MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2.miRNA-365a-3p 通过靶向 RUNX2 抑制成骨分化促进骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7766-7774. doi: 10.26355/eurrev_201909_18986.
9
MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2.MicroRNA-449b-5p 通过靶向 Satb2 抑制 BMSCs 的成骨分化来促进骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6394-6403. doi: 10.26355/eurrev_201908_18519.
10
LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2.长链非编码 RNA GAS5 通过靶向 microRNA-498 调控 RUNX2 促进骨髓间充质干细胞成骨分化从而缓解骨质疏松的发生。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7757-7765. doi: 10.26355/eurrev_201909_18985.

引用本文的文献

1
The Involvement of microRNAs in Bone Remodeling Signaling Pathways and Their Role in the Development of Osteoporosis.微小RNA在骨重塑信号通路中的作用及其在骨质疏松症发展中的角色
Biology (Basel). 2024 Jul 7;13(7):505. doi: 10.3390/biology13070505.
2
Common miRNAs of Osteoporosis and Fibromyalgia: A Review.骨质疏松症和纤维肌痛的常见 miRNA:综述。
Int J Mol Sci. 2023 Aug 31;24(17):13513. doi: 10.3390/ijms241713513.
3
Sharing Circulating Micro-RNAs between Osteoporosis and Sarcopenia: A Systematic Review.骨质疏松症与肌肉减少症之间循环微小RNA的共享:一项系统综述
Life (Basel). 2023 Feb 21;13(3):602. doi: 10.3390/life13030602.
4
microRNA-29b-3p/sirtuin-1/peroxisome proliferator-activated receptor γ suppress osteogenic differentiation.微小RNA-29b-3p/沉默调节蛋白1/过氧化物酶体增殖物激活受体γ抑制成骨分化。
In Vitro Cell Dev Biol Anim. 2023 Feb;59(2):109-120. doi: 10.1007/s11626-023-00753-7. Epub 2023 Mar 7.
5
Osteoporosis pathogenesis and treatment: existing and emerging avenues.骨质疏松症的发病机制和治疗:现有和新兴途径。
Cell Mol Biol Lett. 2022 Sep 4;27(1):72. doi: 10.1186/s11658-022-00371-3.
6
The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.非编码RNA在人骨髓间充质干细胞成骨分化中的新兴作用
Front Cell Dev Biol. 2022 May 16;10:903278. doi: 10.3389/fcell.2022.903278. eCollection 2022.
7
The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.多发性骨髓瘤中lncRNAs的格局:对“癌症特征”的影响、临床前景及治疗机会
Cancers (Basel). 2022 Apr 13;14(8):1963. doi: 10.3390/cancers14081963.
8
The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.微小 RNA 在骨骼疾病中的新兴作用及其治疗潜力。
Molecules. 2021 Dec 30;27(1):211. doi: 10.3390/molecules27010211.
9
Expression of LINC01606 in multiple myeloma and its effect on cell invasion and migration.LINC01606在多发性骨髓瘤中的表达及其对细胞侵袭和迁移的影响。
Am J Transl Res. 2021 Aug 15;13(8):8777-8786. eCollection 2021.
10
Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures.微小RNA在人类骨质疏松症和脆性骨折中的应用:文献系统综述
Int J Mol Sci. 2021 May 15;22(10):5232. doi: 10.3390/ijms22105232.